Quanterix Corporation (QTRX)Healthcare | Medical Devices | Billerica, United States | NasdaqGM
3.06 USD
-0.09
(-2.857%) ⇩
(Oct. 14, 2026, 4 p.m.
EDT)
After hours: 3.06 |
Hot Take ↕ | Oct. 10, 2026, 6:26 a.m. EDT
The investment case here is severely compromised by a deteriorating business model. The company is burning significant cash, with operating cash flow and free cash flow both deeply negative, while returning to shareholders via share conversions rather than dividends. Fundamentally, the stock is trading at a loss with negative returns on equity and assets, and the market has punished this reality hard, driving the price down nearly 70% over the last seven years. While recent revenue growth looks promising on paper, the multi-year price trajectory confirms that investors remain deeply skeptical of the path to profitability. The recent surge in price is likely driven by speculative hype around new medical device approvals, but the underlying financials—negative margins and massive cash burn—suggest this rally lacks a sustainable foundation. With no dividend to provide income and a balance sheet that is hemorrhaging cash, the risk-reward profile remains skewed heavily toward the downside. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.174181 |
| AutoARIMA | 0.181098 |
| AutoETS | 0.183869 |
| AutoTheta | 0.261952 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 35% |
| H-stat | 0.86 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.190 |
| Excess Kurtosis | -0.90 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 14.075 |
| Revenue per Share | 3.28 |
| Market Cap | 144,716,768 |
| Forward P/E | -2.25 |
| Beta | 1.01 |
| Profit Margins | -80.25% |
| Website | https://www.quanterix.com |
As of Oct. 10, 2026, 6:26 a.m. EDT: Speculators are positioning for a continued decline, evidenced by heavy out-of-the-money put open interest relative to calls. The lack of call volume above the current price suggests a bearish bias, while the absence of protective puts indicates traders are not hedging against further drops.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.45501733 |
| Address1 | Building 1 |
| Address2 | 900 Middlesex Turnpike |
| All Time High | 92.57 |
| All Time Low | 2.15 |
| Ask | 4.68 |
| Ask Size | 2 |
| Audit Risk | 10 |
| Average Analyst Rating | 3.0 - Hold |
| Average Daily Volume10 Day | 609,880 |
| Average Daily Volume3 Month | 770,078 |
| Average Volume | 770,078 |
| Average Volume10Days | 609,880 |
| Beta | 1.013 |
| Bid | 2.73 |
| Bid Size | 2 |
| Board Risk | 6 |
| Book Value | 5.033 |
| City | Billerica |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 7 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 3.06 |
| Current Ratio | 3.396 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 3.23 |
| Day Low | 3.05 |
| Debt To Equity | 14.075 |
| Display Name | Quanterix |
| Dividend Yield | 0.0 |
| Earnings Call Timestamp End | 1,786,365,000 |
| Earnings Call Timestamp Start | 1,786,365,000 |
| Earnings Timestamp | 1,786,365,000 |
| Earnings Timestamp End | 1,794,227,400 |
| Earnings Timestamp Start | 1,794,227,400 |
| Ebitda | -70,504,000 |
| Ebitda Margins | -0.45958 |
| Enterprise To Ebitda | -1.26 |
| Enterprise To Revenue | 0.579 |
| Enterprise Value | 88,831,152 |
| Eps Current Year | -1.23 |
| Eps Forward | -1.36 |
| Eps Trailing Twelve Months | -2.61 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 3.0392 |
| Fifty Day Average Change | 0.020799875 |
| Fifty Day Average Change Percent | 0.006843865 |
| Fifty Two Week Change Percent | -45.50173 |
| Fifty Two Week High | 8.77 |
| Fifty Two Week High Change | -5.7100005 |
| Fifty Two Week High Change Percent | -0.6510833 |
| Fifty Two Week Low | 2.15 |
| Fifty Two Week Low Change | 0.90999985 |
| Fifty Two Week Low Change Percent | 0.4232557 |
| Fifty Two Week Range | 2.15 - 8.77 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,512,657,000,000 |
| Float Shares | 37,985,790 |
| Forward Eps | -1.36 |
| Forward P E | -2.25 |
| Free Cashflow | -29,915,250 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 450 |
| Fullday Change | -0.09000015 |
| Fullday Change Percent | -2.8571477 |
| Fullday Price | 3.06 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,790,812,800 |
| Gross Margins | 0.44561002 |
| Gross Profits | 68,360,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.06368 |
| Held Percent Institutions | 0.71229 |
| Implied Shares Outstanding | 47,293,065 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, the company offers contract research and clinical laboratory testing services, including research and clinical trial testing, and lucent diagnostic services. The company primarily operates in the areas of neurology, oncology and immunology, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and sales force and distributors. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts. |
| Long Name | Quanterix Corporation |
| Market | us_market |
| Market Cap | 144,716,768 |
| Market State | POST |
| Max Age | 86,400 |
| Message Board Id | finmb_47689694 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -123,108,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 149,446,085 |
| Number Of Analyst Opinions | 3 |
| Open | 3.1 |
| Operating Cashflow | -80,919,000 |
| Operating Margins | -0.68367 |
| Overall Risk | 6 |
| Phone | 617 301 9400 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 3.06 |
| Post Market Time | 1,792,008,105 |
| Previous Close | 3.15 |
| Price Eps Current Year | -2.487805 |
| Price Hint | 4 |
| Price To Book | 0.6079873 |
| Price To Sales Trailing12 Months | 0.9433395 |
| Profit Margins | -0.80248 |
| Quick Ratio | 2.3 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | hold |
| Recommendation Mean | 3.0 |
| Region | US |
| Regular Market Change | -0.09000015 |
| Regular Market Change Percent | -2.8571475 |
| Regular Market Day High | 3.23 |
| Regular Market Day Low | 3.05 |
| Regular Market Day Range | 3.05 - 3.23 |
| Regular Market Open | 3.1 |
| Regular Market Previous Close | 3.15 |
| Regular Market Price | 3.06 |
| Regular Market Time | 1,792,008,000 |
| Regular Market Volume | 342,261 |
| Return On Assets | -0.16667 |
| Return On Equity | -0.46485 |
| Revenue Growth | 0.344 |
| Revenue Per Share | 3.28 |
| Sand P52 Week Change | 0.17004645 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 3 |
| Shares Outstanding | 47,293,065 |
| Shares Percent Shares Out | 0.1067 |
| Shares Short | 5,046,958 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 4,817,511 |
| Short Name | Quanterix Corporation |
| Short Percent Of Float | 0.1201 |
| Short Ratio | 5.6 |
| Source Interval | 15 |
| State | MA |
| Symbol | QTRX |
| Target High Price | 3.5 |
| Target Low Price | 3.0 |
| Target Mean Price | 3.16667 |
| Target Median Price | 3.0 |
| Total Cash | 93,529,000 |
| Total Cash Per Share | 1.978 |
| Total Debt | 33,387,000 |
| Total Revenue | 153,408,992 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -2.61 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 4.119325 |
| Two Hundred Day Average Change | -1.0593252 |
| Two Hundred Day Average Change Percent | -0.2571599 |
| Type Disp | Equity |
| Volume | 342,261 |
| Website | https://www.quanterix.com |
| Zip | 1,821 |